Orange Book product · Generic (ANDA)
GEMFIBROZIL
GEMFIBROZIL
At a glance
Jan 29, 1993
Approved
Generic (ANDA)
Application
Not listed
TE code
None
Listed patents
Key dates
Approval
FDA approval date of this drug product.
Jan 29, 1993
33 yr 10 mo ago
Today
Pharmaceutical detail
Active ingredient
GEMFIBROZIL
Strength
300MG
Dosage form
CAPSULE
Route
ORAL
TE code
Not listed
Application
ANDA 072929
Product number
001
Marketing status
DISCN
Reference listed drug (RLD)
No
Reference standard (RS)
No
Active-ingredient family
View full familyGeneric (ANDA) of GEMFIBROZIL
- —LOPIDBrand (NDA)
NDA 018422 · PFIZER PHARMS
- 2021GEMFIBROZILGeneric (ANDA)
ANDA 214603 · ASCENT PHARMS INC
- 2018GEMFIBROZILGeneric (ANDA)
ANDA 204189 · CADILA
- 2016GEMFIBROZILGeneric (ANDA)
ANDA 203266 · CADILA PHARMS LTD
- 2015GEMFIBROZILGeneric (ANDA)
ANDA 202726 · AUROBINDO PHARMA LTD
- 2010GEMFIBROZILGeneric (ANDA)
ANDA 079072 · NORTHSTAR HLTHCARE
- 2010GEMFIBROZILGeneric (ANDA)
ANDA 078599 · HIKMA PHARMS
- 2008GEMFIBROZILGeneric (ANDA)
ANDA 079239 · SUN PHARM INDS INC
- 2007GEMFIBROZILGeneric (ANDA)
ANDA 078207 · IMPAX PHARMS
- 2007GEMFIBROZILGeneric (ANDA)
ANDA 078012 · EPIC PHARMA LLC
- 2006GEMFIBROZILGeneric (ANDA)
ANDA 077836 · INVAGEN PHARMS
- 1998GEMFIBROZILGeneric (ANDA)
ANDA 075034 · APOTEX
Listed patents
No patents are listed against this product in the Orange Book. Listed patents reflect those the NDA holder submits under 21 U.S.C. 355 and are not exhaustive.
